Atopic Dermatitis (eczema)
We are currently enrolling patients in a clinical trial who have moderate to severe atopic dermatitis (eczema). To qualify, you must:
- Be age 18 to 54 years at screening
- Have a diagnosis of atopic dermatitis (eczema) for at least 1 year
- Have atopic dermatitis involvement of greater than 10% body surface area
- Women of childbearing potential must use a highly effective form of birth control
The trial will investigate how the study medication affects the severity and extent of atopic dermatitis and if the study drug can affect the body’s immune response to vaccinations.
Study medications and visits provided at no charge.
To find out more, please contact our study coordinator:
Janel Shelton, MS, MPAS, PA-C